Titan Pharmaceuticals, Inc. Current Assets
Titan Pharmaceuticals, Inc. had Current Assets of $3.05 million as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-08-14
- 2025-06-30: Assets, Current $3.05M.
- 2025-03-31: Assets, Current $2.16M.
- 2024-12-31: Assets, Current $2.92M.
- 2024-09-30: Assets, Current $3.60M.
| Period end | Assets, Current |
|---|---|
| 2025-06-30 | $3.05M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.16M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.92M 10-Q · filed 2025-08-14 |
| 2024-09-30 | $3.60M 10-Q · filed 2025-01-03 |
| 2024-06-30 | $4.35M 10-Q · filed 2024-08-15 |
| 2024-03-31 | $6.61M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $8.02M 10-K · filed 2025-03-20 |
| 2023-09-30 | $9.90M 10-K · filed 2024-04-01 |
| 2023-06-30 | $498.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.78M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.60M 10-K · filed 2024-04-01 |
| 2022-09-30 | $5.75M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.71M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $9.63M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.23M 10-K · filed 2023-03-31 |
| 2021-09-30 | $8.85M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $10.63M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $13.19M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $7.33M 10-K · filed 2022-03-25 |
| 2020-09-30 | $6.65M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $8.69M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $12.15M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $8.31M 10-K · filed 2021-03-31 |
| 2019-09-30 | $3.95M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $5.49M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $10.09M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $13.30M 10-K · filed 2020-03-30 |
| 2018-09-30 | $11.53M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $4.19M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $4.75M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $8.31M 10-K/A · filed 2019-04-02 |
| 2017-09-30 | $12.06M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $8.75M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $12.31M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $17.83M 10-K · filed 2018-04-02 |
| 2016-09-30 | $22.68M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $24.39M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $10.99M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $12.24M 10-K · filed 2017-03-16 |
| 2015-09-30 | $13.85M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $16.21M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $17.20M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $19.58M 10-K · filed 2016-03-15 |
| 2014-09-30 | $11.86M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $12.81M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $14.61M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $16.82M 10-K · filed 2015-03-31 |
| 2013-09-30 | $13.85M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $15.23M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $21.96M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $23.43M 10-K · filed 2014-03-31 |
| 2012-09-30 | $9.38M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $8.82M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $6.74M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $9.96M 10-K · filed 2013-03-18 |
| 2011-09-30 | $6.47M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $8.75M 10-Q/A · filed 2011-08-17 |
| 2010-12-31 | $4.70M 10-K · filed 2012-03-15 |